Why is Transgene Biotek falling/rising?

As of 03-Sep, Transgene Biotek Ltd is experiencing a price increase, currently trading at 3.85, which reflects a rise of 0.11 or 2.94%. Despite this positive movement today, the stock has shown a significant decline over the past month, down 16.30%, and a year-to-date drop of 43.63%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a longer-term bearish trend. However, there has been a notable increase in investor participation, with delivery volume rising by 456.25% compared to the 5-day average, suggesting renewed interest among investors. Unfortunately, there are no specific positive or negative factors provided to further explain the stock's recent movement.
In the broader market context, Transgene Biotek's short-term performance has outpaced the benchmark Sensex, which has decreased by only 0.27% over the past week. This indicates that while the stock has faced substantial challenges over longer periods, its recent uptick today may be a response to increased trading activity, even as it continues to lag behind the benchmark in terms of overall returns. The stark contrast between the stock's recent performance and its longer-term declines highlights the volatility and potential for recovery, albeit within a challenging market environment.